SEBI orders forensic audit against Sun Pharma based on whistle-blower complaint: Sources

New Delhi, Sept 03 : The Securities and Exchange Board of India (SEBI) has ordered a forensic audit against India’s largest drugmaker Sun Pharma to look into allegations of financial irregularities and lapses in corporate governance standards, two sources have told Moneycontrol.
“SEBI has ordered a forensic audit to confirm the findings of its initial inquiry,” a senior SEBI official told Moneycontrol on condition of anonymity.
The development was confirmed by another person privy to the proceedings.
SEBI has been poring over Sun Pharma’s books of accounts to look into red flags raised by the whistle-blower in his complaint.